We found that the alteration of Mio and additional proof-of-concept candidates, such as glycolysis genes, MODY homologues, insulin (Dilp) and glucagon (Akh), all produced hyperglycaemia in a manner predicted from mammalian studies. The gene discussed is INS; the disease is Hyperglycemia.